KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Share-based Compensation (2016 - 2026)

TherapeuticsMD filings provide 16 years of Share-based Compensation readings, the most recent being $2000.0 for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 91.3% to $2000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $54000.0, a 69.32% decrease, with the full-year FY2025 number at $75000.0, down 71.59% from a year prior.
  • Share-based Compensation hit $2000.0 in Q1 2026 for TherapeuticsMD, down from $51000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.3 million in Q3 2022 to a low of $1000.0 in Q2 2025.
  • Median Share-based Compensation over the past 5 years was $113500.0 (2023), compared with a mean of $704437.5.
  • The widest YoY moves for Share-based Compensation: up 112.5% in 2025, down 98.96% in 2025.
  • TherapeuticsMD's Share-based Compensation stood at $1.1 million in 2022, then plummeted by 89.45% to $116000.0 in 2023, then crashed by 79.31% to $24000.0 in 2024, then surged by 112.5% to $51000.0 in 2025, then crashed by 96.08% to $2000.0 in 2026.
  • The last three reported values for Share-based Compensation were $2000.0 (Q1 2026), $51000.0 (Q4 2025), and $1000.0 (Q2 2025) per Business Quant data.